.RESEARCH HIGHLIGHT.06 August 2024.
A large randomized measured test along with cisgender ladies highlights the difficulties of adherence to an everyday oral preexposure prevention regiment as well as displays that twice-yearly injection of lenacapavir can maintain effective HIV prevention levels over 6 months.